Offer - Urjas Oil for just ₹ 1 X
Nimodip 30 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Brain Hemorrhage. Secondary and off-label uses of Nimodip 30 Mg Tablet have also been mentioned below.
The right dosage of Nimodip 30 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Nimodip 30 Mg Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Nimodip 30 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Nimodip 30 Mg Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Nimodip 30 Mg Tablet related warnings talks about Nimodip 30 Mg Tablet's effects on the liver, heart and kidney.
Nimodip 30 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Nimodip 30 Mg Tablet in conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Liver Disease. The section on Nimodip 30 Mg Tablet contraindications lists all such conditions.
Drug reaction of Nimodip 30 Mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Nimodip 30 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Nimodip 30 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nimodip 30 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Nimodip. If you are pregnant, do not take Nimodip without a doctor's advice.
Is the use of Nimodip 30 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Nimodip. So it is adviced to consult the doctor before using it.
What is the effect of Nimodip 30 Mg Tablet on the Kidneys?
Nimodip is completely safe for kidneys.
What is the effect of Nimodip 30 Mg Tablet on the Liver?
In the absence of any scientific study on the side effects of Nimodip on the liver, information on safety of Nimodip for liver is unavailable.
What is the effect of Nimodip 30 Mg Tablet on the Heart?
Nimodip is rarely harmful for the heart.
Nimodip 30 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nimodip 30 Mg Tablet unless your doctor advises you to do so -
Is this Nimodip 30 Mg Tablet habit forming or addictive?
Nimodip 30 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nimodip 30 Mg Tablet, you should not drive or work on any heavy machine, as Nimodip 30 Mg Tablet can make you drowsy.
Is it safe?
Yes, Nimodip 30 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Nimodip 30 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Nimodip 30 Mg Tablet
Nimodip 30 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Nimodip 30 Mg Tablet
Consuming Nimodip 30 Mg Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nimotop® (nimodipine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 911-913